Your browser doesn't support javascript.
loading
NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis.
Yan, J; Greer, J M.
Affiliation
  • Yan J; The University of Queensland Centre for Clinical Research, Royal Brisbane & Women's Hospital, Brisbane, Queensland, 4029, Australia. j.yan@uq.edu.au
CNS Neurol Disord Drug Targets ; 7(6): 536-57, 2008 Dec.
Article in En | MEDLINE | ID: mdl-19128210
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: NF-kappa B / Drug Delivery Systems / Multiple Sclerosis Limits: Animals / Humans Language: En Journal: CNS Neurol Disord Drug Targets Journal subject: NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country: Australia Country of publication: Emiratos Árabes Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: NF-kappa B / Drug Delivery Systems / Multiple Sclerosis Limits: Animals / Humans Language: En Journal: CNS Neurol Disord Drug Targets Journal subject: NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country: Australia Country of publication: Emiratos Árabes Unidos